NCT01953510 - Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam | Biotech Hunter

Enrollment

1,400

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 27, 2016

Study Completion Date

November 8, 2021

Conditions

Pneumococcal Vaccines

Interventions

BIOLOGICAL

PCV10

PCV10 includes serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F and protein D is the main carrier protein

BIOLOGICAL

PCV13

PCV13 includes serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, individually linked to non-toxic diphtheria CRM197 carrier protein

Trial Locations (1)

Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City